Stay updated on RadioSurgery and Nivolumab for Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study page now presents the full record for a trial combining radiosurgery and nivolumab for brain metastases, including participant criteria, study design, outcome measures, and locations, instead of an access-denied error.
    Difference
    56%
    Check dated 2026-11-07T13:12:17.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:50:25.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:28:20.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:34:18.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:24:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page (with a DOCTYPE header and minimal navigation) instead of the study record content. This indicates an access issue to the page rather than an update to the study data.
    Difference
    20%
    Check dated 2026-09-19T20:39:56.000Z thumbnail image

Stay in the know with updates to RadioSurgery and Nivolumab for Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RadioSurgery and Nivolumab for Brain Metastases Clinical Trial page.